• Türkçe
    • English
  • English 
    • Türkçe
    • English
  • Login
View Item 
  •   DSpace Home
  • İktisadi ve İdari Bilimler Fakültesi
  • Sağlık İdaresi Bölümü
  • Sağlık İdaresi Bölümü Tez Koleksiyonu
  • View Item
  •   DSpace Home
  • İktisadi ve İdari Bilimler Fakültesi
  • Sağlık İdaresi Bölümü
  • Sağlık İdaresi Bölümü Tez Koleksiyonu
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Türkiye’de Uygulanan İlaç Politikaları Konusunda Paydaşların Görüş Ve Tercihlerinin Çok Kriterli Karar Verme Yöntemi (Electre Iıı) İle Değerlendirilmesi

View/Open
10199486.pdf (5.065Mb)
Date
2018
Author
Demir, Canan
xmlui.mirage2.itemSummaryView.MetaData
Show full item record
Abstract
Along with the changes in the disease structure resulting from aging population, increased awareness of health and access to services have increased the need for effective selection and use of health policies. An important part of these health policies is pharmaceutical policy. Pharmaceutical pricing and reimbursement policies are expected to meet the needs of individuals on time, maintain the effective use of resources and support research and development activities. These expectations differ according to each stakeholder, and these differences directly affect the preferences of the stakeholder groups. With this study, it is aimed to reveal the differences in opinions and preferences of stakeholders regarding pharmaceutical policies. A questionnaire was applied to determine the preferences of four different stakeholder groups on pharmaceutical policy and a total of 179 questionnaire results were collected and analyzed. The analysis of the results was made with Multi Criteria Decision Making tool ELECTRE III. According to the results, the most important policiy objectives are access to pharmaceuticals, sustainability of healthcare system and control of pharmaceutical spending. Accelerated authorization and reimbursement processes have been found the most effective tools to achieve the stated objectives. This was followed by pharmacoeconomic evaluation and alternative reimbursement contracts, respectively. When the preferences of the stakeholder groups are analyzed separately, it is found that stakeholders have similar views on policy objectives, but with respect to tools, preferences are different. It is expected that the results of this research will guide the decision makers while evaluating existing policies and creating new ones.
URI
http://hdl.handle.net/11655/5402
xmlui.mirage2.itemSummaryView.Collections
  • Sağlık İdaresi Bölümü Tez Koleksiyonu [75]
Hacettepe Üniversitesi Kütüphaneleri
Açık Erişim Birimi
Beytepe Kütüphanesi | Tel: (90 - 312) 297 6585-117 || Sağlık Bilimleri Kütüphanesi | Tel: (90 - 312) 305 1067
Bizi Takip Edebilirsiniz: Facebook | Twitter | Youtube | Instagram
Web sayfası:www.library.hacettepe.edu.tr | E-posta:openaccess@hacettepe.edu.tr
Sayfanın çıktısını almak için lütfen tıklayınız.
Contact Us | Send Feedback



DSpace software copyright © 2002-2016  DuraSpace
Theme by 
Atmire NV
 

 


DSpace@Hacettepe
huk openaire onayı
by OpenAIRE

About HUAES
Open Access PolicyGuidesSubcriptionsContact

livechat

sherpa/romeo

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeDepartmentPublisherLanguageRightsIndexing SourceFundingxmlui.ArtifactBrowser.Navigation.browse_subtypeThis CollectionBy Issue DateAuthorsTitlesSubjectsTypeDepartmentPublisherLanguageRightsIndexing SourceFundingxmlui.ArtifactBrowser.Navigation.browse_subtype

My Account

LoginRegister

Statistics

View Usage Statistics

DSpace software copyright © 2002-2016  DuraSpace
Theme by 
Atmire NV